What is OpGen, Inc.'s current stock price?

OpGen, Inc. (OPGN) currently trades at USD 23.91. Track real-time price changes and historical performance on AllInvestView.

What sector is OpGen, Inc. in?

OpGen, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

OpGen, Inc. OPGN · Stock Open OpGen, Inc. in new tab

23.91 USD

Add to portfolio

P/E

137.50

EPS

0.18

P/B

24.53

ROE

104.13

Beta

-3052.63

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for OpGen, Inc. (OPGN)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

OpGen, Inc. Analysis (OPGN)

United States Health Care Official Website Stock

Is OpGen, Inc. a good investment? OpGen, Inc. (OPGN) is currently trading at 23.91 USD.

In terms of valuation, the stock trades at a P/E ratio of 137.50. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: OpGen, Inc. is expected to release its next earnings report on April 2, 2026. The market consensus estimate for Forward EPS is -0.29.

Investor FAQ

Does OpGen, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is OpGen, Inc.?

OpGen, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be April 2, 2026. The company currently has a trailing EPS of 0.18.

Company Profile

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

Exchange Ticker

NCM (Australia) OPGN

LSE (United Kingdom) 0A8L.L

FRA (Germany) 6502.F

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Jan. 19, 2018	0.040000
Aug. 29, 2019	0.050000
Jan. 5, 2023	0.050000
May 20, 2024	0.100000

OpGen, Inc. OPGN · Stock Open OpGen, Inc. in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

OpGen, Inc. Analysis (OPGN)

Investor FAQ

Company Profile

Fundamentals

Under Construction

OpGen, Inc. OPGN · Stock Open OpGen, Inc. in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

OpGen, Inc. Analysis (OPGN)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications